Table II.
Correlation between IgE and various factors in patients with Meniere’s disease
| Variables | p | r |
|---|---|---|
| Age | 0.074 | 0.177 |
| Sex | 0.299 | −0.103 |
| Side | 0.750 | 0.032 |
| Age of onset | 0.150 | 0.143 |
| Duration | 0.122 | 0.153 |
| Relationship with posture | 0.464 | 0.073 |
| Ophthalmologic symptoms | 0.373 | 0.089 |
| Balance dysfunction | 0.182 | −0.133 |
| Family history | 0.590 | 0.054 |
| Migraine | 0.329 | −0.097 |
| Allergy | 0.034* | 0.209 |
| Autoimmune disease | 0.835 | 0.021 |
| Hypertension | 0.157 | 0.141 |
| Coronary heart disease | 0.412 | −0.082 |
| Hyperlipidemia | 0.720 | −0.036 |
| Diabetes | 0.280 | 0.108 |
| Smoking | 0.605 | −0.052 |
| IL-4 | 0.007* | 0.260 |
| Grading of endolymphatic hydrops | 0.000* | 0.353 |
| Hearing stage | 0.000* | 0.350 |
| Functional level | 0.034* | 0.209 |
Grading of endolymphatic hydrops using magnetic resonance imaging according to the four-stage grading system. Hearing stage and functional level were measured according to the American Academy Otolaryngology 1995 guidelines. The correlation analysis between IgE and various factors was done using Spearman’s correlation coefficient (r).
*
p < 0.05.